⌘K

Login Start Free

Home/Filings/4/0001628280-25-013531

4//SEC Filing

Bitterman Chris T. 4

Accession 0001628280-25-013531

CIK 0001087294other

View on SEC.gov Company Profile

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 5:11 PM ET

Size

5.2 KB

Accession

0001628280-25-013531

Insider Transaction Report

Form 4

Period: 2025-03-17

CUMBERLAND PHARMACEUTICALS INCCPIX

Bitterman Chris T.

Vice Pres Sales & Marketing

Transactions

Award
Options (right to buy)
2025-03-17$5.17/sh+2,750$14,218→ 16,000 total
Exercise: $5.17From: 2029-03-17Exp: 2035-03-17→ Common Stock (2,750 underlying)

Documents

1 file

4
wk-form4_1742332253.xmlPrimary
FORM 4

Issuer

CUMBERLAND PHARMACEUTICALS INC

CIK 0001087294

Entity typeother

Related Parties

1

filerCIK 0001969681

Filing Metadata

Form type: 4
Filed: Mar 17, 8:00 PM ET
Accepted: Mar 18, 5:11 PM ET
Size: 5.2 KB

View on SEC.gov